A recent study investigated the correlation between the specific anti-spike SARS-CoV-2 IgG immune response resulting from vaccination or previous infection, viral load, and fecal virus excretion, as well as their impact on the clinical characteristics …
Human herpesviruses comprise the alpha, beta, and gamma subfamilies and are a widely prevalent group of DNA-enveloped viruses capable of establishing lifelong latent infections in humans and causing various diseases. Among them, herpes simplex virus (H…
Researchers at the Technion’s Ruth and Bruce Rappaport Faculty of Medicine and the Rappaport Family Institute for Research in the Medical Sciences have discovered a subset of blood cells that predict the success of immunotherapy treatment. These findin…
The American Academy of Otolaryngology–Head and Neck Surgery Foundation has published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy in Otolaryngology–Head and Neck Surgery. This clinical practice guideline identifies quality impro…
According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth most common condition treated with antibiotics, accou…
Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells. The journal Blood has published the preclinical…
A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses induced by COVID-19 vaccines are long-lasting. The study results, published online in the journal Immunity challeng…
In an early-phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer. The findings are published in Cancer.
El direccionamiento de la terapia celular a esta molécula resulta en la destrucción de las células tumorales y de sus fibroblastos asociados, los cuales son clave en la progresión del cáncer. Investigadores de la Universidad de Amberes han generado células natural killer portadoras de receptores quiméricos (NK-CAR) que reconocen el antígeno CD70, el cual es … Read more
Un trabajo español ha probado de forma preclínica un nuevo tipo de inmunoterapia frente al mieloma múltiple MADRID, ESPAÑA/ ABC DIGITAL.— Una nueva inmunoterapia, basada en células STAb, ha demostrado en laboratorio ser más eficaz que la inmunoterapia actualmente preferida, las células CART-T, en el tratamiento del mieloma múltiple, el segundo cáncer hematológico más común en adultos. … Read more
